- Home
- YOU vs ZLAB Comparison
YOU vs ZLAB Comparison
Compare YOU & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YOU
- ZLAB
- Stock Information
- Founded
- YOU 2010
- ZLAB 2013
- Country
- YOU United States
- ZLAB China
- Employees
- YOU N/A
- ZLAB N/A
- Industry
- YOU Computer Software: Prepackaged Software
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- YOU Technology
- ZLAB Health Care
- Exchange
- YOU Nasdaq
- ZLAB Nasdaq
- Market Cap
- YOU 3.5B
- ZLAB 4.0B
- IPO Year
- YOU 2021
- ZLAB 2017
- Fundamental
- Price
- YOU $34.91
- ZLAB $30.76
- Analyst Decision
- YOU Buy
- ZLAB Buy
- Analyst Count
- YOU 5
- ZLAB 6
- Target Price
- YOU $34.40
- ZLAB $57.22
- AVG Volume (30 Days)
- YOU 1.5M
- ZLAB 511.6K
- Earning Date
- YOU 08-05-2025
- ZLAB 08-07-2025
- Dividend Yield
- YOU 2.21%
- ZLAB N/A
- EPS Growth
- YOU 105.20
- ZLAB N/A
- EPS
- YOU 1.59
- ZLAB N/A
- Revenue
- YOU $835,529,000.00
- ZLAB $427,799,000.00
- Revenue This Year
- YOU $15.96
- ZLAB $42.62
- Revenue Next Year
- YOU $10.87
- ZLAB $55.12
- P/E Ratio
- YOU $21.86
- ZLAB N/A
- Revenue Growth
- YOU 19.85
- ZLAB 32.56
- 52 Week Low
- YOU $21.67
- ZLAB $19.16
- 52 Week High
- YOU $38.88
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- YOU 57.16
- ZLAB 37.68
- Support Level
- YOU $35.08
- ZLAB $28.71
- Resistance Level
- YOU $36.68
- ZLAB $33.97
- Average True Range (ATR)
- YOU 0.99
- ZLAB 1.17
- MACD
- YOU -0.20
- ZLAB -0.39
- Stochastic Oscillator
- YOU 43.58
- ZLAB 25.43
About YOU Clear Secure Inc.
Clear Secure Inc is an identity company making experiences safer and easier digitally and physically. It is involved in the creation of a frictionless travel experience while enhancing security. Its secure identity platform uses biometrics to automate the identity verification process through lanes in airports which helps to make the travel experience safe and easy.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.